methylene blue has been researched along with MS (Multiple Sclerosis) in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| da Mota, ACC; da Silva, VVB; Dadalti Fragoso, Y; Gonçalves, MLL; Horácio Pinto, E; Horliana, ACR; Kalil Bussadori, S; Melo Deana, A; Miranda França, C | 1 |
| HOLM, V | 1 |
| Beguin, C; Carton, H; D'Hooghe, MB; Dooms, G; Lissoir, F; Sindic, CJ; van de Wyngaert, FA | 1 |
2 trial(s) available for methylene blue and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effect of photodynamic therapy in the reduction of halitosis in patients with multiple sclerosis: clinical trial.
Topics: Adult; Aged; Anti-Infective Agents; Breath Tests; Case-Control Studies; Female; Halitosis; Humans; Male; Methylene Blue; Middle Aged; Multiple Sclerosis; Photochemotherapy; Photosensitizing Agents; Quality of Life; Young Adult | 2017 |
A double-blind clinical trial of mitoxantrone versus methylprednisolone in relapsing, secondary progressive multiple sclerosis.
Topics: Adult; Alopecia; Contrast Media; Double-Blind Method; Female; Follow-Up Studies; Gadolinium; Humans; Immunosuppressive Agents; Lymphocyte Count; Magnetic Resonance Imaging; Male; Methylene Blue; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Nausea; Patient Dropouts; Phlebitis; Pulmonary Embolism; Pyrrolidines; Recurrence; Severity of Illness Index; Treatment Outcome; Vomiting | 2001 |
1 other study(ies) available for methylene blue and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
[Methylene blue method (Steen's test) in blood analysis in disseminated sclerosis].
Topics: Blood; Hematologic Tests; Humans; Methylene Blue; Multiple Sclerosis | 1955 |